ABT Stock Analysis: Abbott Laboratories
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancr
- Latest close
- $98.83
- 20-day change
- -9.27%
- Trend state
- LEAN BEAR
- Classification
- Healthcare · Medical - Devices
Market context
Abbott Laboratories moved -9.27% over the latest 20-session window. BullRecon currently classifies the broader setup as LEAN BEAR.
Latest report
The latest cached company filing period (FY2025 · $44.3B revenue · $6.5B net income) is used alongside annual and quarterly history. Values remain tied to their reported period.
Six-dimension read
Health is currently the strongest dimension at 5.2/6, while Growth is the lowest at 3.1/6. Scores are comparative research signals, not forecasts.